Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Obesity × Exenatide × Clear all

Phase

Phase 3 2 Phase 4 1 Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 3 Overweight 1 Obesity 1

Interventions

Metformin 6 Exercise 3 Liraglutide 2 Docosahexaenoic Acids 2 Diet 2 sibutramine 1 semaglutide 1 Ursodeoxycholic Acid 1 Topiramate 1 Tirzepatide 1 Propofol 1 Nutrition Therapy 1 Nutrition Assessment 1 Exenatide 1 Doxorubicin 1 Cyclophosphamide 1 Caloric Restriction 1 (2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03352869 2019-09-11

Research of Exenatide for Overweight/Obese PCOS Patients With IGR

RenJi Hospital

Phase 4 Completed

Obesity, Polycystic Ovary Syndrome, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon ⚡